Morris Arlene — SEC Form 4 filings
SEC reporting owner CIK 1362520. 14 Form 4 filings on record with FilingPulse; latest filed 2026-08-31.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-05-07 to 2026-08-31. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 45,510 shares, $1,689,493 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
- Largest priced transaction: sale of 42,349 shares @ $37.09 ($1,570,830) in Cogent Biosciences, Inc., filed 2026-08-31.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | Director | 4 | — | 2 legs · 45,510 sh · $1,689,493 | 7 |
| PALATIN TECHNOLOGIES INC (PTN) | Director | 3 | — | — | 5 |
| Edgewise Therapeutics, Inc. (EWTX) | Director | 4 | — | — | 4 |
| Viridian Therapeutics, Inc.\DE (VRDN) | Director | 3 | — | — | 3 |
Form 4 filings — Morris Arlene
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-31 | 4 | Cogent Biosciences, Inc. (COGT) | Option exercise (M): 41,927 @ $5.64 · Option exercise (M): 3,583 @ $2.52 · Sale (S): 42,349 @ $37.09 · Sale (S): 3,161 @ $37.54 · Option exercise (M): 41,927 (derivative) @ $0 · Option exercise (M): 3,583 (derivative) @ $0 | EDGAR |
| 2026-08-05 | 4 | PALATIN TECHNOLOGIES INC (PTN) | Code (Z): 2,400 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/award (A): 32,341 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Grant/award (A): 16,377 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 17,901 (derivative) @ $0 | EDGAR |
| 2025-12-11 | 4 | PALATIN TECHNOLOGIES INC (PTN) | Grant/award (A): 2,400 (derivative) @ $0 · Grant/award (A): 2,400 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/award (A): 21,000 (derivative) @ $0 | EDGAR |
| 2025-06-18 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 44,700 (derivative) @ $0 | EDGAR |
| 2024-07-16 | 4 | PALATIN TECHNOLOGIES INC (PTN) | Grant/award (A): 12,000 @ $0 · Grant/award (A): 17,000 (derivative) @ $0 | EDGAR |
| 2024-06-28 | 4 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/award (A): 21,000 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 44,700 (derivative) @ $0 | EDGAR |
| 2024-06-12 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Grant/award (A): 20,594 (derivative) @ $0 | EDGAR |
| 2024-05-07 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Grant/award (A): 34,311 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1362520 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →